References
- Centers for Disease Control and Prevention. Condoms and STDs: Fact Sheet for Public Health Personnel. Updated July 2014. http://www.cdc.gov/condomeffectiveness/latex.htm.
- World Health Organization. Sexually transmitted infections (STIs). Fact sheet No.110. Updated November 2013. http://www.who.int/mediacentre/factsheets/fs110/en/.
- BY Holt, M Kilbourne-Brook, A Stone. Multipurpose prevention technologies for sexual and reproductive health: gaining momentum and promise. Contraception. 81: 2010; 177–180. 10.1016/j.contraception.2009.11.009.
- Centers for Disease Control and Prevention. Male circumcision. Updated April 2013. http://www.cdc.gov/hiv/prevention/research/malecircumcision/.
- www.cami-health.org/.
- C Celum, R Morrow, D Donnell. Daily oral tenofovir and emtricitabine-tenofovir pre-exposure prophylaxis reduces Herpes Simplex Virus Type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial. Annals of Internal Medicine. 161: 2014; 11–19. 10.7326/M13-2471.
- JM Baeten, D Donnell, P Ndase. Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women. New England Journal of Medicine. 367: 2012; 399–410. 10.1056/NEJMoa1108524.
- RM Grant, JR Lama, PL Anderson. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 363: 2010; 2587. 10.1056/NEJMoa1011205.
- Q Karim, S Karim, J Frohlich. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 329(5996): 2010; 1168–1174. 10.1126/science.1193748.
- FACTS Consortium, 2014. http://www.facts-consortium.co.za/.
- International Partnership for Microbicides. http://www.ipmglobal.org/publications/ipm-receives-award-usaid-advance-dual-purpose-prevention-ring.
- Population Council. Developing ARV-based Microbicide and Microbicide/Contraceptive Vaginal Rings. http://www.popcouncil.org/research/developing-arv-based-microbicide-and-microbicide-contraceptive-vaginal-ring.
- CONRAD. CONRAD’s TFV LNG Intravaginal ring in the news. http://www.conrad.org/news-pressreleases-93.html.
- PATH. A new kind of diaphragm. http://www.path.org/projects/silcs.php.
- PATH. A unique kind of condom: Woman’s Condom expands choices for protection. http://www.path.org/projects/womans_condom.php.
- Starpharma. VivaGel® condom receives TGA device certification - Launch preparations to follow. http://www.starpharma.com/news/201.
- Osel. MucoCept: a Technology Platform. http://oselinc.com/site/research-development/mucocept/.
- National Institutes of Health. HIV vaccine research. Updated July 2014. http://www.niaid.nih.gov/topics/hivaids/research/vaccines/Pages/default.aspx.
- National Institutes of Health. NIH launches trial of investigational genital herpes vaccine. Updated November 2013. http://www.nih.gov/news/health/nov2013/niaid-08.htm.
- JU Igietseme, FO Eko, CM Black. Chlamydia vaccines: recent developments and the role of adjuvants in future formulations. Expert Reviews of Vaccines. 10: 2011; 1585–1596. 10.1586/erv.11.139.
- W Zhu, C-J Chen, CE Thomas. Vaccines for gonorrhoea: can we rise to the challenge?. Frontiers in Microbiology. 2: 2011; 124. 10.3389/fmicb.2011.00124.
- RK Naz. Contraceptive vaccines: success, status, and future perspective. American Journal of Reproductive Immunology. 66: 2011; 2–4. 10.1111/j.1600-0897.2011.00999.x.
- Garg S, Anderson RA, Chany CJ, et al. Properties of a new acid buffering bioadhesive vaginal formulation (Acidform). Contraception 2001;64:67–75. Doi: 10.1016/s0010-7824(01)00217-724.
- World Health Organization and Contraceptive Research and Development Program. Technical consultation on nonoxynol-9. 2002; WHO: Geneva.
- World Health Organization. Sexual and reproductive health: Hormonal contraception and HIV. 2014. http://www.who.int/reproductivehealth/topics/family_planning/hc_hiv/en/.
- M Aldunate, D Tyssen, A Johnson. Vaginal concentrations of lactic acid potently inactivate HIV. Journal of Antimicrobial Chemotherapy. 68: 2013; 2015–2025. 10.1093/jac/dkt156.
- DE O’Hanlon, TR Moench, RA Cone. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infectious Diseases. 11: 2011; 200. 10.1186/1471-2334-11-200.
- A Tuyama, N Cheshenko, M Carlucci. Amphora inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. Journal of Infectious Diseases. 194: 2006; 795–803. 10.1086/506948.
- SE Spencer, IE Valentin-Bon, K Whaley. Inhibition of Neisseria gonorrhoeae genital tract infection by leading candidate topical microbicides in a mouse model. Journal of Infectious Diseases. 189: 2004; 410–419. 10.1086/381125.
- JW Tapsall, F Ndowa, DA Lewis. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Review of Anti-infective Therapy. 7: 2009; 821–834. 10.1586/eri.09.63.
- F Ndowa, M Lusti-Narasimhan. The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity. Reproductive Health Matters. 20(40): 2012; 76–82. 10.1016/S0968-8080(12)40653-X.
- Tevi-Bennison C, Citron D, Crowell A, et al. Acidform: an acid-buffering and bio-adhesive gel with activity against bacterial vaginosis and Trichomonas vaginalis in vitro. Abstract #MoPeD3659, XIV International AIDS Conference, Barcelona, 7–12 July 2002.
- DF Harp, I Chowdhury. Trichomoniasis: evaluation to execution. European Journal of Obstetrics and Gynecology and Reproductive Biology. 157: 2011; 3–9. 10.1016/j.ejogrb.2011.02.024.
- MJ Keller, CA Carpenter, Y Lo. Phase 1 randomized safety study of twice daily dosing of Acidform vaginal gel: candidate antimicrobial contraceptive. PLOS One. 7(10): 2012; e46901. 10.1371/journal.pone.0046901.